Filtered By:
Source: Circulation
Condition: Heart Failure
Cancer: Cancer

This page shows you your search results in order of date.

Order by Relevance | Date

Total 2 results found since Jan 2013.

Aromatase Inhibitors and the Risk of Cardiovascular Outcomes in Women With Breast Cancer: A Population-Based Cohort Study.
CONCLUSIONS: In this population-based study, aromatase inhibitors were associated with increased risks of heart failure and cardiovascular mortality compared with tamoxifen. There were also trends toward increased risks, although nonsignificant, of myocardial infarction and ischemic stroke. The increased risk of cardiovascular events associated with aromatase inhibitors should be balanced with their favorable clinical benefits compared with tamoxifen. PMID: 32065766 [PubMed - in process]
Source: Circulation - February 17, 2020 Category: Cardiology Authors: Khosrow-Khavar F, Filion KB, Bouganim N, Suissa S, Azoulay L Tags: Circulation Source Type: research

Return to the Workforce Following First Hospitalization for Heart Failure: A Danish Nationwide Cohort Study.
CONCLUSIONS: -Patients in the workforce prior to HF hospitalization had low mortality but high risk of detachment from the workforce one year later. Young age, male sex, and higher level of education were predictors of return to work. PMID: 27507406 [PubMed - as supplied by publisher]
Source: Circulation - August 8, 2016 Category: Cardiology Authors: Rørth R, Wong C, Kragholm K, Fosbøl E, Mogensen UM, Lamberts M, Petrie MC, Jhund PS, Gerds TA, Torp-Pedersen C, Gislason GH, McMurray JJ, Køber L, Kristensen SL Tags: Circulation Source Type: research